Boldabol Inject

General information:

CAS Name: 1,4-androstadiene-3-one,17β-ol

boldabol

boldabol-injectable

Boldenone undecylenate is a derivative of testosterone with similar androgenic activity and higher mytrophic activity. Boldenone undecylenate does not convert into estrogens and does not have estrogen-related side effects. Instead, boldenone undecylenate is converted by 5-alpha-reductase into dihydroboldenone and some of it’s androgenic effect mediated by dihydroboldenone.

Boldenone undecylenate increases overall body metabolism rate and increases appetite. Increase in lean body mass and low side effects make this anabolic/androgenic steroid (AAS) a good therapeutic choice for age-related non-genomic muscle degenerative diseases like sarcopenia. The undecylenate ester extends half-life of boldenone in circulation, which, depending on dose, is approximately seven days.

Just test table
Each ml contains:
Boldenone Undecylenate 200 mg
Arachis Oil BP q.s.

Packing: 10 mL Glass Vial

Additional information:

Dosage and administration

Effective adult dose (male): 200-600mg per week by intramuscular injection
Effective adult dose (female): 50-100mg per week by intramuscular injection

Contraindications

Contraindicated in men with carcinomas of the breast or with known or suspected carcinomas of the prostate and in women who are or may become pregnant. When administered to pregnant women, androgens cause virilization of the external genitalia of the female fetus.

Adverse reactions

Geriatric patients treated with androgens may be at an increased risk for the development of prostatic hypertrophy and prostatic carcinoma. The same precautions have to be taken as with other AAS convertible into DHT.